Canada's Access to Medicines Regime background
In August 2003, negotiations among World Trade Organization (WTO) members resulted in a landmark decision to waive two licensing provisions of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) that appeared to prevent the export of generic drugs and medical devices to developing countries faced with public health problems.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Canada's Access to Medicines Regime backgroundHTMLEnglish publication HTML
Canada's Access to Medicines Regime backgroundHTMLFrench publication HTML